Entera Bio (ENTX.US) Latest Stock News - Major News Analysis

Event Tracking

Dec23

Entera Bio Ltd. Receives FDA Regulatory Decision on Osteoporosis Drug Development

13:30

Nov15

Entera Bio released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0679 (forecast USD -0.09)

04:00

Entera Bio released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 42K, actual EPS USD -0.1838

04:00

Aug9

Entera Bio released FY2025 Semi-Annual earnings on August 8 (EST), actual revenue USD 0, actual EPS USD -0.0567

03:00

Entera Bio released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0567 (forecast USD -0.11)

03:00

Aug8

Entera Bio Ltd. Announces Q2 2025 Financial Report and Plans to Submit EB613 IND Application to FDA

20:09

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.2 M, EPS -0.0679

Aug8

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.656 M, EPS -0.0567

May9

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 42 K, Net Income -2.567 M, EPS -0.0591

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change